Back

Effect of semaglutide on global longitudinal strain and global myocardial work efficiency in patients with uncontrolled type 2 diabetes mellitus and obesity.

27 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Diabetes and the heart (3) Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Giuseppe Armentaro

University Hospital Renato Dulbecco, Catanzaro (Italy)

6 More presentations in this session

Presentation thumbnail
Risk of incident renal cell carcinoma in patients with type 2 diabetes on sodium-glucose co-transporter-2 inhibitor users: a population-based cohort study
Professor G. Jong (Taichung, TW)
Abstract Slides Video
Presentation thumbnail
Fifteen-year follow-up and impact of age and sex on cardiovascular outcomes in diabetes and non-diabetes patients without CAD
Doctor P. Thrane (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Impact of glycated hemoglobin A1c on cardiovascular risk in diabetes patients with and without coronary artery disease
Doctor M. Hansen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
The impact of glycated hemoglobin A1c on cardiovascular risk in patients with and without coronary artery disease
Doctor K. Olesen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Elevated remnant cholesterol in atherosclerotic cardiovascular disease in diabetes: a population-based prospective cohort study
Doctor B. Nilsson Wadstrom (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Diabetes and the heart (3)

The Event

Event poster

ESC Congress 2023

27 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of oral semaglutide on global longitudinal strain and global myocardial work efficiency in patients with HFpEF, uncontrolled type 2 diabetes mellitus and obesity.
thumbnail
Congress Presentation
Association of GDF15, NTpoBNP and PLGF with subclinical cardiac dysfunction in type 2 diabetes: effects of novel antidiabetic treatment.
thumbnail
Congress Presentation
Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on mitochondrial-derived peptide-c and on markers of neurohumoral activation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources